Novartis to buy 85% of Chinese vaccines producer

Nov 4, 2009 27 related

TEL AVIV (MarketWatch) -- Novartis AG, the Basel health-care giant, said on Wednesday that it definitively agreed to acquire 85% of the closely held Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co. for about... [read full story]

Add Comment

There are also 27 related articles

View all news articles about*:

Aviv China Israel Medicines Novartis Pharmaceuticals Remedies Tel Vaccines

*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

Send to a friend | Bookmark with

NewstinMap

Click to Open NewstinMap —

Visual Navigation

My Newstin

Context

Pharmaceuticals
Medicines & Remedies
Vaccines

Novartis

Tel Aviv District
Israel
Tel Aviv
China

Intelligent Data Fusion

About Us

Visit our corporate homepage to learn more about our company and products.

Novartis to buy 85% of Chinese vaccines producer

View other selected articles:

Beginning Or End Of Holiday Shopping?

Roger Wiegand: $2,960 Gold on the Horizon? (at Seeking Alpha)

Fireballs spotted in Edmonton sky

Mother gets up to 20 years for urine test scheme

International Editions